购物车
- 全部删除
- 您的购物车当前为空
Anti-HGFR/c-Met Antibody (5O93) 是一种 Rabbit 抗体,靶向 HGFR/c-Met。Anti-HGFR/c-Met Antibody (5O93) 可用于 ELISA。
Anti-HGFR/c-Met Antibody (5O93) 是一种 Rabbit 抗体,靶向 HGFR/c-Met。Anti-HGFR/c-Met Antibody (5O93) 可用于 ELISA。
产品描述 | Anti-HGFR/c-Met Antibody (5O93) is a Rabbit antibody targeting HGFR/c-Met. Anti-HGFR/c-Met Antibody (5O93) can be used in ELISA. |
Ig Type | Monoclonal Rabbit IgG |
克隆号 | 5O93 |
交叉反应 | Canine |
应用 | ELISA |
推荐剂量 | ELISA: 1:5000-1:10000 |
抗体种类 | Monoclonal |
宿主来源 | Rabbit |
构建方式 | This antibody was obtained from a rabbit immunized with purified, recombinant Canine HGFR / c-MET (TMPY-02068; NP_001002963.1; Met1-Leu935). |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | Hepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR protein is produced as a single-chain precursor, and HGF is the only known ligand. Normal HGF/HGFR signaling is essential for embryonic development, tissue repair, or wound healing, whereas aberrantly active HGFR has been strongly implicated in tumorigenesis, particularly in the development of invasive and metastatic phenotypes. HGFR protein is a multifaceted regulator of growth, motility, and invasion, and is normally expressed by cells of epithelial origin. Preclinical studies suggest that targeting aberrant HGFR signaling could be an attractive therapy in cancer.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
偶联 | Unconjugated |
免疫原 | Recombinant Canine HGFR / c-MET protein (TMPY-02068) |
抗原种属 | Canine |
研究领域 | Cancer Drug Targets, Receptor Tyrosine Kinases (RTKs) |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容